Poorly versus moderately differentiated hepatocellular carcinoma: Vascularity assessment by computed tomographic hepatic angiography in correlation with histologically counted number of unpaired arteries

Journal of Computer Assisted Tomography

Volumn 31, Issue 2, 2007, Pages 188-192

  Asayama, Yoshiki ^a   Yoshimitsu, Kengo ^a   Irie, Hiroyuki ^a   Nishihara, Yunosuke ^a   Aishima, Shinichi ^a   Tajima, Tsuyoshi ^a   Hirakawa, Masakazu ^a   Ishigami, Kousei ^a   Kakihara, Daisuke ^a   Taketomi, Akinobu ^a   Honda, Hiroshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Artery; CT; Hepatocellular carcinoma

Indexed keywords

COMPUTERIZED TOMOGRAPHY; TUMORS;

ARTERIAL BLOOD; ARTERY; BLOOD SUPPLY; CLASSIFIEDS; COMPUTED TOMOGRAPHIC; CONTRAST ENHANCEMENT; CT; HEPATOCELLULAR CARCINOMA;

ANGIOGRAPHY;

NONIONIC CONTRAST MEDIUM;

ARTERIAL BLOOD; ARTICLE; CANCER INVASION; CANCER SURGERY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; HEPATIC ARTERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE QUALITY; LIVER ANGIOGRAPHY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUMOR VASCULARIZATION;

EID: 34147108745     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rct.0000236417.82395.57     Document Type: Article

References (21)

1. Okuda K. Hepatocellular carcinoma: clinicopathological aspects. J Gastroenterol Hepatol. 1997;12:314-318.
2. Nakajima Y, Shimamura T, Kamiyama T, et al. Evaluation of surgical resection for small hepatocellular carcinomas. Am J Surg. 1996;171:360-363.
3. Pomfret EA, Pomposelli JJ, Lewis WD, et al. Live donor adult liver transplantation using right lobe grafts: donor evaluation outcome. Arch Surg. 2001;136:425-433.
4. Inomato Y, Uemoto S, Asonuma K, et al. Right lobe graft in living donor liver transplantation. Transplantation. 2000;69:258-264.
5. Wachs ME, Bak TE, Karrer FM, et al. Adult living donor liver transplantation using a right hepatic lobe. Transplantation. 1998;66:1313-1316.
6. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg. 1998;228:479-490.
7. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology. 2001;33:1080-1086.
8. Kim CK, Lim JH, Park CK, et al. Neoangiogenesis and sinusoidal capillarization in hepatocellular carcinoma: correlation between dynamic CT and density of tumor microvessels. Radiology. 2005;237:529-534.
9. Bossi P, Viale G, Lee AK, et al. Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res. 1995;55:5049-5053.
10. Tajima T, Honda H, Taguchi K, et al. Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. AJR Am J Roentgenol. 2002;178:885-897.
11. Hayashi M, Matsui O, Ueda K, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol. 1999;172:969-976.
12. Ueda K, Terada T, Nakanuma Y, et al. Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study. Hum Pathol. 1992;23:619-626.
13. Kwak BK, Shim HJ, Park ES, et al. Hepatocellular carcinoma: correlation between vascular endothelial growth factor level and degree of enhancement by multiphase contrast-enhanced computed tomography. Invest Radiol. 2001;36:487-492.
14. Almen T. Relations between chemical structure, animal toxicity and clinical adverse effects of contrast media. In: Enge I, Edgren J, eds. Patient Safety and Adverse Events in Contrast Medium Examinations. Amsterdam, The Netherlands: Elsevier Science; 1989:25-56.
15. von Marschall Z, Cramer T, Hocker M, et al. Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma. Gut. 2001;48:87-96.
16. Kanematsu M, Osada S, Amaoka N, et al. Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver: correlation with angiographically assisted CT. AJR Am J Roentgenol. 2004;183:1585-1593.
17. Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation. Nature. 2000;407:242-248.
18. Tanaka S, Sugimachi K, Yamashita YY, et al. Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma. Hepatology. 2002;35:861-867.
19. Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat. 1995;36:127-137.
20. Kawahara N, Ono M, Taguchi K, et al. Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma. Hepatology. 1998;28:1512-1517.
21. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;14(334):693-699.